A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
More than 2 years after the child was born, no identifiable features of SMA have been observed, reported Richard Finkel, MD, of St. Jude Children's Research Hospital in Memphis, Tennessee, and ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results